Target : International, multicenter, randomized trial evaluating the impact of pre-treatment with the new platelet inhibitor prasugrel (Efient®) in patients with acute coronary syndrome undergoing coronary angioplasty

Trial date : 2009

Number of patients : 4 033

Source of funding : Private (Eli Lilly & Daiichi Sankyo)

Centers participating : 171 centers in 19 country

N°NCT : NCT01015287

STATUS

Design in Am Heart J. – apr 2011

Publication in N Engl J Med. – sep 2013

Publication in J Am Coll Cardiol. – dec 2014

Publication in J Am Coll Cardiol. – apr 2015

Publication in Heart. – aug 2015

Publication in Am Heart J. – nov 2015

Publication in JACC Cardiovasc Interv. – may 2016

Publication in Eur Heart J Acute Cardiovasc Care. – june 2016